MakeMyTrip (MMYT) has been back in focus after analysts raised earnings estimates in unison, coupled with a top-tier ranking from Zacks that has coincided with fresh momentum in the stock.

That optimism has been tested in the short term, with MakeMyTrip’s share price falling 8.6% over the last day and 6.5% over the past week, even after a 12.0% 30 day share price return and 13.2% 90 day share price return. These sit against a year to date share price decline of 36.9% and a 1 year total shareholder return decline of 49.3%, while the 3 year and 5 year total shareholder returns of 80.8% and 79.8% respectively show how sentiment around the stock has shifted over different time frames as investors weigh higher earnings estimates against past volatility.

If recent analyst upgrades have you looking beyond a single stock, this could be a good moment to broaden your search with the 18 top founder-led companies

After a sharp pullback following a strong short term rebound, MakeMyTrip now trades at around $51.64, while analyst targets are clustered closer to $71.90. Does it make more sense to step in here or wait for a different entry based on valuation?

Most Popular Narrative: 27% Undervalued

At a last close of $51.64 versus a narrative fair value of about $70.73, the current pricing for MakeMyTrip sits well below what the most followed narrative is working with. This puts the focus firmly on what that narrative expects from the business.

Ongoing investment in product innovation, particularly in AI-powered personalization and user experience improvements, positions MakeMyTrip for higher conversion rates, better customer retention, and ultimately supports expanding net margins through improved operating leverage.

Want to see what is built into that valuation gap? The narrative considers faster revenue growth, rising profitability, and a richer earnings multiple. The detailed playbook sits inside the full narrative.

Result: Fair Value of $70.73 (UNDERVALUED)

However, there are still clear risks to that MakeMyTrip narrative, including intense competition from global and domestic rivals and ongoing exposure to India focused geopolitical shocks that can quickly hit travel demand.

Another View on MakeMyTrip’s Valuation

The fair value narrative suggests MakeMyTrip looks about 27% undervalued at $51.64 versus $70.73, but the earnings multiple tells a very different story. The stock trades on a P/E of 94.6x, compared with 23.7x for the US Hospitality industry, 30.1x for peers, and a fair ratio of 41.7x that the market could move towards.

That kind of premium can point to rich expectations and valuation risk rather than a clear margin of safety. Which signal do you weigh more heavily when forming your own view on MakeMyTrip?

Next Steps

Seeing mixed signals around MakeMyTrip’s valuation and narrative? Use the full set of numbers, risks, and potential rewards to shape your own view with the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond MakeMyTrip?

If MakeMyTrip has you thinking more seriously about your portfolio, use this moment to line up your next moves with some focused stock ideas.

• Target resilient income by scanning companies that appear built to support higher payouts with the 7 dividend fortresses.
• Spot potential value opportunities early by reviewing companies flagged in the 47 high quality undervalued stocks before the crowd turns its attention to them.
• Strengthen your portfolio’s foundation by zeroing in on companies highlighted in the solid balance sheet and fundamentals stocks screener (49 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.